Research location
Santa Fe
New Mexico, United States
Advertisement
Research activity in Santa Fe
New Mexico, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 155 trials and 158 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Santa Fe
155 linked trials · page 2 of 4Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Bictegravir (GS-9883) in Human Immunodeficiency Virus (HIV)-1 Infected ParticipantsNCT02275065 · 2014-10-24 · 1 site observation
COMPLETED
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)NCT02194738 · 2014-09-26 · 1 site observation
ACTIVE_NOT_RECRUITING
Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDFNCT02121795 · 2014-05-06 · 1 site observation
COMPLETED
A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral RegimenNCT02105987 · 2014-04-01 · 1 site observation
COMPLETED
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or MetastaticNCT02115282 · 2014-03-29 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)NCT02076178 · 2014-03-27 · 1 site observation
COMPLETED
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing SurgeryNCT01953588 · 2014-02-27 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected AdultsNCT02071082 · 2014-02-25 · 1 site observation
COMPLETED
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With ChemotherapyNCT01901094 · 2014-02-24 · 1 site observation
ACTIVE_NOT_RECRUITING
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast CancerNCT02003209 · 2014-02-18 · 1 site observation
COMPLETED
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infectionNCT02073656 · 2014-02-01 · 1 site observation
COMPLETED
Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate CancerNCT01949337 · 2014-01-22 · 1 site observation
UNKNOWN
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast CancerNCT01674140 · 2013-09-12 · 1 site observation
ACTIVE_NOT_RECRUITING
Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive AdultsNCT01968551 · 2013-09-03 · 1 site observation
COMPLETED
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and SurgeryNCT01872975 · 2013-08-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive ParticipantsNCT01815736 · 2013-03-27 · 1 site observation
COMPLETED
Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal ImpairmentNCT01818596 · 2013-03-27 · 1 site observation
COMPLETED
Study to Evaluate the Safety and Efficacy of E/C/F/TAF Versus E/C/F/TDF in HIV-1 Positive, Antiretroviral Treatment-Naive AdultsNCT01797445 · 2013-03-12 · 1 site observation
COMPLETED
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate CancerNCT01809691 · 2013-03-08 · 1 site observation
COMPLETED
Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive AdultsNCT01780506 · 2012-12-26 · 1 site observation
COMPLETED
Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected AdultsNCT01667731 · 2012-07-01 · 1 site observation
COMPLETED
S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast CancerNCT01515800 · 2012-05-01 · 1 site observation
COMPLETED
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerNCT01547741 · 2012-04-01 · 1 site observation
COMPLETED
Irinotecan for Previously Treated, Advanced, Non-Small Cell Lung CancerNCT01607554 · 2012-04-01 · 1 site observation
TERMINATED
Effectiveness of V-Go™ for Patients With Diabetes in a Real-world SettingNCT01326598 · 2012-01-01 · 1 site observation
COMPLETED
Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-TNCT01543152 · 2011-12-01 · 1 site observation
COMPLETED
A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)NCT01467479 · 2011-12-01 · 1 site observation
TERMINATED
Study of an Investigational Glucose Meter SystemNCT01474317 · 2011-11-01 · 1 site observation
COMPLETED
Navigator II Continuous Glucose Monitor Home Use StudyNCT01455064 · 2011-10-01 · 1 site observation
COMPLETED
S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone TherapyNCT01309672 · 2011-08-09 · 1 site observation
COMPLETED
Safety and Tolerability of Crofelemer for HIV-Associated DiarrheaNCT01374490 · 2011-06-07 · 1 site observation
COMPLETED
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast CancerNCT01272037 · 2011-02-28 · 1 site observation
ACTIVE_NOT_RECRUITING
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate CancerNCT01306890 · 2011-01-27 · 1 site observation
COMPLETED
Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV InfectionNCT01199731 · 2010-10-05 · 1 site observation
TERMINATED
Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected SubjectsNCT01165203 · 2010-09-30 · 1 site observation
COMPLETED
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes AdultsNCT01103284 · 2010-04-01 · 1 site observation
COMPLETED
Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive AdultsNCT01108510 · 2010-04-01 · 1 site observation
COMPLETED
NeuroStar TMS Therapy System: Utilization and OutcomesNCT01114477 · 2010-03-01 · 1 site observation
COMPLETED
Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected PatientsNCT01044654 · 2009-12-01 · 1 site observation
COMPLETED
A Pilot Study Assessing the Integrase Inhibitor GSK1349572 in HIV-infected Persons With Virus Resistant to RaltegravirNCT00950859 · 2009-08-01 · 1 site observation
COMPLETED
A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive SubjectsNCT00951015 · 2009-07-30 · 1 site observation
COMPLETED
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving ChemotherapyNCT00858364 · 2009-07-17 · 1 site observation
TERMINATED
A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast CancerNCT00938652 · 2009-07-01 · 1 site observation
COMPLETED
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast CancerNCT00887536 · 2009-05-01 · 1 site observation
COMPLETED
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive AdultsNCT00892437 · 2009-05-01 · 1 site observation
COMPLETED
Study of the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive AdultsNCT00869557 · 2009-04-01 · 1 site observation
COMPLETED
A Study of Trastuzumab Emtansine Versus Capecitabine + Lapatinib in Participants With HER2-positive Locally Advanced or Metastatic Breast CancerNCT00829166 · 2009-02-01 · 1 site observation
COMPLETED
Rapid HIV Testing and Counseling in Drug Abuse TreatmentNCT00809445 · 2009-01-01 · 1 site observation
COMPLETED
Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus RaltegravirNCT00708162 · 2008-07-01 · 1 site observation
COMPLETED
Phase IIa Dose-ranging Study of GSK1349572 in HIV-1 Infected AdultsNCT00708110 · 2008-06-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.